Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MRNA Moderna, Inc. Common Stock
$48.58 -6.00% -3.11
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MRNA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 19.0B
Enterprise value 16.5B
Trailing PE 24.96875
Forward PE -7.482408
PEG Ratio -0.013871527777778
Enterprise to EBITDA -5.067
Enterprise to revenue 7.39
Price to book MRQ 2.173749
Price to sales TTM 9.080355

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 2.2B
EBITDA -3255000064
Diluted EPS TTM -8.06
Total Cash (MRQ) 4.5B
Current ratio (MRQ) 3.925
Operating Cash Flow (TTM) -1978000000

MRNA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months
Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.